Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 06-2008 | 12-2007 | 06-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 5,670 | 5,130 | 400 | 380 |
| Marketable Securities | N/A | 500 | 500 | 250 | 1,600 |
| Receivables | N/A | 0 | 0 | 0 | 70 |
| Other current assets | 820 | 180 | 50 | 110 | 60 |
| TOTAL | $820 | $6,350 | $5,680 | $760 | $2,110 |
| Non-Current Assets | |||||
| PPE Net | N/A | 5 | 5 | 8 | 9 |
| Other Non-Current Assets | 4,357 | 4,267 | 3,637 | 2,547 | 2,477 |
| TOTAL | $4,357 | $4,272 | $3,642 | $2,555 | $2,486 |
| Total Assets | $5,177 | $10,640 | $9,340 | $3,320 | $4,610 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 460 | 370 | 550 | 100 | 130 |
| Accrued Expenses | 410 | 310 | 360 | 370 | 240 |
| Other current liabilities | 0 | 0 | 4 | 10 | 20 |
| TOTAL | $870 | $680 | $920 | $500 | $400 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 111 | 120 | 370 | 120 | 130 |
| TOTAL | $111 | $120 | $370 | $120 | $130 |
| Total Liabilities | $981 | $800 | $1,300 | $630 | $530 |
| Shareholders' Equity | |||||
| Common Shares | 190 | 180 | 170 | 170 | 170 |
| Retained earnings | N/A | -30,220 | -27,290 | -25,620 | -24,100 |
| Other shareholders' equity | 0 | 0 | -10 | 10 | 0 |
| TOTAL | $40,840 | $9,830 | $8,030 | $2,690 | $4,080 |
| Total Liabilities And Equity | $41,821 | $10,630 | $9,330 | $3,320 | $4,610 |